Volume 12, Issue 2 (10-2024)
Jorjani Biomed J 2024, 12(2): 14-18 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Juibari S, Rashedi A, Mojerloo M, Mohammadi Z, Amirkhanlou S. Clinical and epidemiological analysis of COVID-19 in End-Stage Renal Disease patients undergoing maintenance hemodialysis: A study from Golestan province. Jorjani Biomed J 2024; 12 (2) :14-18
URL: http://goums.ac.ir/jorjanijournal/article-1-979-en.html
URL: http://goums.ac.ir/jorjanijournal/article-1-979-en.html
1- Clinical Research Development Unit (CRDU), Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran
2- Department of Hemodialysis, 5th Azar Hospital, Gorgan, Iran
3- Metabolic Disorders Research Center, Golestan University of Medical Sciences, Golestan, Iran
4- Clinical Research Development Unit (CRDU), Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran ,drsam74ir@ymail.com
2- Department of Hemodialysis, 5th Azar Hospital, Gorgan, Iran
3- Metabolic Disorders Research Center, Golestan University of Medical Sciences, Golestan, Iran
4- Clinical Research Development Unit (CRDU), Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran ,
Abstract: (1176 Views)
Background: End-Stage Renal Disease (ESRD) patients under maintenance hemodialysis are at higher risk for COVID-19 and severe outcomes. This study aimed to investigate the association between ESRD patients who underwent maintenance hemodialysis at 5th Azar and Sayad Shirazi Hospital in Golestan Province in 2019 and their risk of contracting and experiencing severe outcomes from COVID-19. Furthermore, this study aimed to provide insights into the epidemic status of COVID-19 in this specific population, contributing to better insight into the unique challenges faced by ESRD patients on hemodialysis during the pandemic.
Methods: This retrospective descriptive cross-sectional study was performed on patients who underwent maintenance hemodialysis. The diagnosis was made based on diagnostic criteria and COVID-19 PCR test. Medical information of all participants was collected. Medical information including clinical, laboratory, and radiological data as well as morbidity and mortality were collected and analyzed by experts. Statistical analysis was performed using SPSS version 21. Normality was evaluated using Shapiro-Wilk test and comparison between groups was analyzed using student T-test and Mann-Whitney U tests (p <0.05).
Results: The highest radiological view was related to the ground glass view with 46.7% and Linear Opacities with 26.7%. Most patients (86.6%) were discharged and four of them (13.4%) passed away. WBC, creatinine, and age were significantly associated with ESRD patients’ mortality (p <0.05). The patients who passed away were old and had higher levels of WBC and creatinine (p > 0.05). No significant difference was observed between the age and BMI of passed away and discharged patients. None of the laboratory parameters in the two groups of passed away and discharged patients with COVID-19 showed a significant difference (p> 0.05). Patients with COVID-19 who had a history of diabetes and hypertension, clinical symptoms, such as cough (p=0.049), weakness, and lethargy (p=0.05), indicated a significant difference in mortality compared to the group that was discharged (p <0.05).
Conclusion: ESRD patients who underwent hemodialysis due to their underlying problems and the crowded environment of dialysis wards more than the general population are at risk of getting COVID-19.
Methods: This retrospective descriptive cross-sectional study was performed on patients who underwent maintenance hemodialysis. The diagnosis was made based on diagnostic criteria and COVID-19 PCR test. Medical information of all participants was collected. Medical information including clinical, laboratory, and radiological data as well as morbidity and mortality were collected and analyzed by experts. Statistical analysis was performed using SPSS version 21. Normality was evaluated using Shapiro-Wilk test and comparison between groups was analyzed using student T-test and Mann-Whitney U tests (p <0.05).
Results: The highest radiological view was related to the ground glass view with 46.7% and Linear Opacities with 26.7%. Most patients (86.6%) were discharged and four of them (13.4%) passed away. WBC, creatinine, and age were significantly associated with ESRD patients’ mortality (p <0.05). The patients who passed away were old and had higher levels of WBC and creatinine (p > 0.05). No significant difference was observed between the age and BMI of passed away and discharged patients. None of the laboratory parameters in the two groups of passed away and discharged patients with COVID-19 showed a significant difference (p> 0.05). Patients with COVID-19 who had a history of diabetes and hypertension, clinical symptoms, such as cough (p=0.049), weakness, and lethargy (p=0.05), indicated a significant difference in mortality compared to the group that was discharged (p <0.05).
Conclusion: ESRD patients who underwent hemodialysis due to their underlying problems and the crowded environment of dialysis wards more than the general population are at risk of getting COVID-19.
Type of Article: Original article |
Subject:
General medicine
Received: 2023/07/21 | Accepted: 2024/04/30 | Published: 2024/12/29
Received: 2023/07/21 | Accepted: 2024/04/30 | Published: 2024/12/29
References
1. Husain SA, Dube G, Morris H, Fernandez H, Chang JH, Kathryn Paget K, et al. Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019. Clin J Am Soc Nephrol. 2020:15(8):1174-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Aziz F, Mandelbrot D, Singh T, Parajuli S, Garg N, Mohamed M, et al. Early Report on Published Outcomes in Kidney Transplant Recipients Compared to Nontransplant Patients Infected With Coronavirus Disease 2019. Transplant Proc. 2020;52(9):2659-62. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Ajaimy M, Melamed ML. COVID-19 in Patients with Kidney Disease. Clin J Am Soc Nephrol. 2020;15(8):1087-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020;35(5):737-41. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. 2020;46(6):1114-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Kooman JP, Sande FM van der. COVID-19 in ESRD and Acute Kidney Injury. Blood Purif. 2021;50(4-5):610-20. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Mohamed MMB, Lukitsch I, Torres-Ortiz AE, Walker JB, Varghese V, Hernandez-Arroyo CF, et al. Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans. Kidney360. 2020;1(7):614-22. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Sharma S, Aggarwal A, Sharma RK, Patras E, Singhal A. Correlation of chest CT severity score with clinical parameters in COVID-19 pulmonary disease in a tertiary care hospital in Delhi during the pandemic period. Egypt J Radiol Nucl Med. 2022;53(1):166. [View at Publisher] [DOI] [Google Scholar]
13. Ajaimy M, Melamed ML. COVID-19 in Patients with Kidney Disease. Clin J Am Soc Nephrol. 2020;15(8):1087-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y, et al. Clinical features of maintenance hemodialysis patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Clin J Am Soc Nephrol. 2020;15(8):1139-45. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Grasselli G, Z A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-81. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831-40. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT, et al. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China. J Am Soc Nephrol. 2020;31(7):1387-97. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, et al. Presentation and Outcomes of Patients with ESKD and COVID-19. J Am Soc Nephrol. 2020;31(7):1409-15. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Kroll MK, Schloer S, Candan P, Korthals N, Wenzel C, Ihle H, et al. Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells. Biomolecules. 2023;13(3):472. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Salazar E, Christensen PA, Graviss EA, Nguyen DT, Castillo B, Jian Chen J, et al. Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality. Am J Pathol. 2020;190(11):2290-303. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv. 2020. [View at Publisher] [DOI] [Google Scholar]
22. Fisher M, Yunes M, Mokrzycki MH, Golestaneh L, Alahiri E, Coco M. Chronic hemodialysis patients hospitalized with COVID-19-short-term outcomes in Bronx, New York. Kidney360. 2020;1(8):755-62. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Du X, Li H, Dong L, Li X, Tian M, Dong J. Clinical features of hemodialysis patients with COVID-19: a single-center retrospective study on 32 patients. Clin Exp Nephrol. 2020;24(9):829-35. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Adwan L, Al-Sadi T, Shawakha S, Al-Shami NA. Clinical outcomes of COVID-19 in hemodialysis patients. Front Med (Lausanne). 2023;10:1281594. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Goicoechea M, Cámara LAS, Macías N, Morales AM, Rojas ÁG, Bascuñana A, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020;98(1):27-34. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Ma Y, Diao B, Lv X, Liang W, Zhu J, Liu L, et al. COVID-19 in hemodialysis (HD) patients: Report from one HD center in Wuhan, China. medRxiv. 2020. [View at Publisher] [DOI] [Google Scholar]
27. Zhou F, YT, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Keller N, Chantrel F, Krummel T, Bazin-Kara D, Faller AL, Muller C, et al. Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: the observational COVIDIAL study. Nephrol Dial Transplant. 2020;35(8):1338-411. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Ma Y, Diao B, Lv X, Zhu J, Chen C, Liu L, et al. Epidemiological, clinical, and immunological features of a cluster of COVID-19-contracted hemodialysis patients. Kidney Int Rep. 2020;5(8):1333-41. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
